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Many transgender people experience high levels of body dissatisfaction, which is one of 
numerous factors known to increase vulnerability to eating disorder symptoms in the cisgender 
(non-trans) population. Cross-sex hormones can alleviate body dissatisfaction so might also 
alleviate eating disorder symptoms. This study aimed to explore risk factors for eating disorder 
symptoms in transgender people and the role of cross-sex hormones. Individuals assessed at a 
national transgender health service were invited (N=563). Transgender people not on cross-sex 
hormones reported higher levels of eating disorder psychopathology than people who were. 
High body dissatisfaction, perfectionism, anxiety symptoms and low self-esteem were risk 
factors for eating psychopathology but, after controlling for these, significant differences in 
eating psychopathology between people who were and were not on cross-sex hormones 
disappeared. Cross-sex hormones may alleviate eating disorder psychopathology. Given the 
high prevalence of transgender identities, clinicians at eating disorder services should assess 
for gender identity issues. 
Key words:  transgender, eating disorder psychopathology, risk factors, cross-sex hormones, 
body dissatisfaction  




Eating disorder psychopathology, which includes restrictive eating, binge eating and 
compensatory behaviours (e.g., self-induced vomiting, misuse of diet pills and laxatives), has 
been found to be more prevalent among adolescent girls and young adult women compared to 
men (e.g., Duncan, Ziobrowski, & Nicol, 2017; Fairburn & Harrison, 2003). Body 
dissatisfaction (i.e., the negative evaluation of one’s appearance; which is also more prevalent 
among adolescents and young people), has consistently been associated with eating disorder 
psychopathology in both females and males (e.g., Keel, Fulkerson, & Leon, 1997; Stice & 
Shaw, 2002; Wang, Lydecker, & Grilo, 2017). Body dissatisfaction is influenced by Western 
society’s view of beauty (e.g., Fitzsimmons-Craft, 2011). As a consequence, women who are 
dissatisfied with their bodies often strive to obtain a thin body, while men are more likely to 
strive to obtain a muscular physique (e.g., Grogan, 2016; McCreary & Sasse, 2000). There are 
certain populations that have been found to be at increased risk of high levels of body 
dissatisfaction, such as the lesbian, gay, bisexual and transgender (LGBT) community (e.g., 
Calzo, Blashill, Brown, & Argenal, 2017; McClain & Peebles, 2016; Morgan & Arcelus, 
2009). Within this group, transgender people are particularly vulnerable to body dissatisfaction 
due to the distress and incongruence they experience with their gender and body, yet this 
population is severely under researched in relation to eating disorders psychopathology (Jones, 
Haycraft, Murjan, & Arcelus, 2016; Witcomb et al., 2015).   
 
Transgender people experience incongruence between their gender assigned at birth 
(determined from their sex characteristics (i.e., genitals)) and the gender they identify with. 
Transgender men are assigned female at birth but identify as male, while transgender women 
are assigned male at birth but identify as female (Arcelus & Bouman, 2017a; Bouman et al., 
2017a). Cisgender people (non-transgender) do not experience such incongruence. Prior to 
Eating disorder psychopathology in transgender people  
4 
 
undergoing gender affirming medical interventions (e.g., cross-sex hormone treatment (CHT), 
gender affirming surgery), many treatment seeking transgender people are dissatisfied with 
their body shape and/or weight, which may put them at risk of developing an eating disorder 
(Witcomb et al., 2015). It has been hypothesised that it is the body dissatisfaction (a common 
feature of eating disorder psychopathology), linked to the wish to achieve a masculine or 
feminine body ideal, which influences the development of eating disorder psychopathology, 
specifically drive for thinness and bulimia, among transgender people (Ålgars, Alanko, 
Santtila, & Sandnabba, 2012; Bouman & Arcelus, 2016; Khoosal, Langham, Palmer, Terry, & 
Minajagi, 2009). In addition, it has also been hypothesised that the wish to stop menstruation 
and puberty, as well as not wanting to develop a feminine body shape (such as the development 
of breasts), can also play a role in the development of an eating disorder in transgender males 
(Bouman & Arcelus, 2016). This may explain why disordered eating has been found to be 
prevalent in transgender adolescents (Watson, Veale, & Saewyc, 2017). For example, Diemer, 
Grant, Munn-Chernoff, Patterson and Duncan (2015) found that transgender adolescents more 
frequently self-reported an eating disorder diagnosis in the past year (15.84%), and presented 
with eating disorder symptoms such as the use of diet pills (13.50%), self-induced vomiting 
and laxative abuse (15.61%), compared to cisgender adolescents.  
 
As well as presenting to transgender health services with symptoms of an eating disorder, 
transgender people may initially present to eating disorder services. Case studies have reported 
on individuals who first present with eating disorder symptoms (e.g., food restriction, vomiting 
and body image distortion) without disclosing their transgender identity which, through 
exploration, has later been expressed as a desire to achieve a masculine or feminine body 
(different to the body associated with their gender assigned at birth) and, hence, identified as 
secondary to their gender identity (e.g., Couturier, Pindiprolu, Findlay, & Johnson, 2015; 
Eating disorder psychopathology in transgender people  
5 
 
Winston, Acharya, Chaudhuri, & Fellowes, 2004). These findings are concerning considering 
that gender incongruence is not routinely assessed within eating disorder services given that 
the prevalence of transgender people is considered to be low. However, recently the prevalence 
of transgender people has increased and there has been a significant increase in demand for 
transgender health services across Europe and North America (Aitken et al., 2015; Arcelus et 
al., 2015; de Vries, Kreukels, T’Sjoen, Ålgars, & Mattila, 2015; House of Commons, 2016; 
Jones et al., 2017). Therefore, gender incongruence may need to be considered by clinicians 
working at eating disorder services.  
 
Within the cisgender population, several factors (such as body dissatisfaction (e.g., Keel et al., 
1997; Stice & Shaw, 2002), high levels of perfectionism (e.g., Egan, Wade, & Shafran, 2011; 
Tchanturia, Larsson, & Adamson, 2016), the existence of interpersonal problems (e.g., 
Arcelus, Haslam, Farrow, & Meyer, 2013), low self-esteem (Dakanalis et al., 2016), symptoms 
of anxiety and depression (e.g., Brechan & Kvalem, 2015; DeBoer & Smits, 2013; Fairburn, 
Cooper, & Shafran, 2003; Harrison, Sullivan, Tchanturia, & Treasure, 2009; Puccio et al., 
2017) have been identified as being associated with eating disorder psychopathology and found 
to increase the risk of developing an eating disorder. Body dissatisfaction has consistently been 
found to be associated with eating disorder psychopathology (e.g., Keel et al., 1997; Stice & 
Shaw, 2002). Dissatisfaction with one’s body has been described as a core feature, but not 
sufficient to completely explain the development of eating disorders (Polivy & Herman, 2002). 
The relationship between eating disorder psychopathology and body dissatisfaction has been 
found to be complex as cognitive behavioural and emotional regulation theories of eating 
disorders have suggested that negative emotions, such as anxiety and depression, as well as 
self-esteem, mediate the relationship between body dissatisfaction and eating disorder 
psychopathology (e.g., Brechan & Kvalem, 2015; DeBoer & Smits, 2013; Fairburn et al., 2003; 
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Harrison et al., 2009). Anxiety symptomatology has also been found to partially mediate the 
association between self-orientated perfectionism (a trait often associated with eating 
disorders; Egan et al., 2011) and eating disorder psychopathology (Egan et al., 2013), which 
suggests that anxiety plays a role in eating disorder development. Furthermore, interpersonal 
difficulties have also been linked to behaviours associated with eating disorders within the 
cisgender population (e.g., Arcelus et al., 2013).  
 
Factors associated with, and found to mediate, eating disorder psychopathology in the 
cisgender population may be particularly pertinent among transgender people. This is because 
research has consistently shown treatment seeking transgender people to report high levels of 
mental health problems, such as anxiety and depression (e.g., Arcelus, Claes, Witcomb, 
Marshall, & Bouman, 2016; Bouman, Davey, Meyer, Witcomb, & Arcelus, 2016a; Bouman et 
al., 2017a; Dhejne, Van Vlerken, Heylens, & Arcelus, 2016; Millet, Longworth, & Arcelus, 
2017), perfectionism (Khoosal et al., 2009), and interpersonal problems (Davey, Bouman, 
Meyer, & Arcelus, 2015) in comparison to cisgender people. Therefore these factors may be 
important when exploring risk factors for eating disorder psychopathology within the 
transgender population.  
 
Once a medical transition has been initiated (e.g., CHT and gender affirming surgery), body 
dissatisfaction has been found to significantly improve in transgender adults (e.g., de Vries, 
Steensma, Doreleijers, & Cohen-Kettenis, 2011, de Vries et al., 2014; Fisher et al., 2014; van 
de Grift et al., 2016, 2017) and, therefore, these interventions may reduce the risk of developing 
an eating disorder or help to alleviate eating disorder symptoms. Although research is limited 
(one study date), eating disorder symptoms have been found to reduce once transgender women 
progress through their medical transition (Khoosal et al., 2009). However, this study only 
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considered the role of surgery and not CHT. The study is also limited by the small sample size 
(N=40) and only recruiting transgender women. In light of this, the current study was 
concerned with exploring the role of CHT only and recruiting a larger sample comprising both 
men and women. In addition to this, this study was concerned with exploring risk factors in 
transgender people yet to undergo a medical transition as this vulnerable population may first 
present to eating disorder services (without disclosing their transgender identity). As the 
cisgender literature suggests that eating disorders are complex and multifactorial this is also 
likely to be the case within the transgender population. Variables that can mediate between 
identified risk factors and eating disorder psychopathology will be explored. These analyses 
within the transgender population are important to determine through which mechanisms 
gender affirming medical interventions (e.g., CHT) are capable of alleviating eating disorder 
symptoms. Taking into consideration some of the limitations of previous research, the study 
had three specific aims: 
1. To examine the role of CHT in eating disorder symptoms by determining whether there 
is a difference in eating disorder psychopathology (drive for thinness and bulimia) 
between a large sample of transgender people who are or who are not on CHT. 
2. To explore risk factors (age, assigned gender, body dissatisfaction, perfectionism, 
interpersonal problems, self-esteem, anxiety, and depression) associated with eating 
disorder psychopathology in transgender people who are not on CHT. 
3. To explore factors that mediate the relationship between identified risk factors and 
eating disorder psychopathology (drive for thinness and bulimia) in transgender people 
who are not on CHT. 
Based on previous research it was first hypothesised that transgender people on CHT would 
have lower levels of eating disorder psychopathology compared to participants who are not on 
cross-sex hormones (e.g., Fisher et al., 2014). Second, it was hypothesised that younger age, 
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identifying as female (because transgender people adopt and perform the social gender role 
(i.e., behaviours, attributes) associated with their experienced gender identity), higher levels of 
body dissatisfaction, anxiety, depression, perfectionism, interpersonal problems and lower 
levels of self-esteem would be risk factors for eating disorder psychopathology in transgender 
people who are not on CHT. Third, based on the centrality of body dissatisfaction to both 
gender incongruence (e.g., Jones et al., 2016) and eating disorders (e.g., Stice & Shaw, 2002), 
it was hypothesised that if a significant relationship was found between body dissatisfaction 
and eating disorder psychopathology (addressed in aim 2), then the other identified risk factors 
would mediate this relationship in people who are not on CHT. 




Participants and recruitment  
All patients offered an assessment at a national transgender health service in the United 
Kingdom (UK) between 2012 and 2015 were invited to take part in the study. This transgender 
health service offers assessment and gender affirming medical interventions to adults aged 17 
and over who are considering, or wish to, medically transition. Patients are assessed by a 
transgender health professional, which could be a psychiatrist, psychologist or nurse specialist. 
The assessment process usually occurs over three appointments, with two different clinicians. 
During the third appointment, patients are invited to bring a relative or friend with them. In 
total, 586 patients were invited for assessment during the study period and 563 (96%) agreed 
to participate (see Table 1 for characteristics of the whole sample). While all participants were 
recruited at the point of assessment, some people had initiated CHT prior to assessment at this 
service (n=139, 24.7%). Some participants may have initiated this intervention as their care 
was transferred from the child and adolescent gender identity development service and others 
might have obtained CHT through private health providers or via the Internet (Mepham, 
Bouman, Arcelus, Hayter, & Wylie, 2014). Table 1 also presents descriptive statistics 
separately for people who were and were not on CHT. In order to have an overall representation 
of patients attending a national transgender health service, no exclusion criteria were applied. 
 
Insert Table 1 here 
Procedure  
Before initial assessment, participants were invited to complete socio-demographic questions 
and a range of self-report measures. This was part of a larger study for which ethical approval 
was obtained from the National Health Service (NHS) ethics committee and from the Research 
and Development Department from the Nottinghamshire Healthcare NHS Foundation Trust in 
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accordance with Health Research Authority guidance (HRA, 2013). Patients were informed 
that they could request a summary of the research findings on completion of the project. No 
patients chose to do this. 
 
Measures  
Socio-demographic information: Participants were asked to provide information about their 
age, gender assigned at birth, and stage of medical transition pre-assessment (e.g., whether they 
were on CHT or not).  They were then invited to complete the following selection of self-report 
measures. 
 
Eating Disorder Inventory-2 (EDI-2; Garner, 1991) 
This questionnaire is commonly used to assess behaviours and psychological traits associated 
with eating disorder psychopathology. It has 11 subscales; three which assess eating-related 
symptoms (drive for thinness, bulimia, and body dissatisfaction) and eight which are associated 
with eating-related psychological features common in eating disorders (ineffectiveness, 
perfectionism, interpersonal distrust, interoceptive awareness, maturity fears, asceticism, 
impulse regulation, and social insecurity). In the current study, the drive for thinness and 
bulimia subscales were used to measure eating disorder psychopathology. The body 
dissatisfaction, perfectionism and interpersonal distrust subscales were also used. Responses 
are rated on a 6-point Likert scale anchored from ‘never’ to ‘always’ and a higher score 
indicates a higher level of eating disorder psychopathology. All the subscales have previously 
been found to have good reliability among patients with an eating disorder and the general 
population (e.g., Nevonen, Clinton, & Norring, 2006). In the current study, the Cronbach alpha 
values were as follows: drive for thinness (α=.85), bulimia (α=.83), body dissatisfaction 
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(α=.85), perfectionism (α=.70) and interpersonal distrust (α=.80), showing that all had good 
reliability.  
 
Rosenberg Self-Esteem Scale (RSE; Rosenberg, 1965)  
This is a 10-item self-report measure that assesses self-esteem using a 4-point Likert scale 
(‘strongly agree’ = 3 to ‘strongly disagree’ = 0). It produces a global score, which is calculated 
by summing the scores from the individual items. A high score indicates a higher self-esteem 
(highest possible score is 30). The measure has been validated and has excellent reliability 
(α=0.88-0.90; Robins, Hendin, & Trzesniewski, 2001). In the current study, the reliability was 
also excellent (α=.92).  
 
Hospital Anxiety and Depression Scale (HADS; Zigmond & Snaith, 1983)  
This measure has 14 items in total, seven which relate to anxiety (HADS-A) and seven which 
relate to depression (HADS-D). The HADS-A and HADS-D subscale scores are calculated by 
summing scores from the individual items. Participants are asked to rate their responses on a 
4-point Likert Scale (‘not at all’ = 1 to ‘most of the time’ = 3). For each subscale, scores 
between 0-7 are considered normal, scores between 8-10 are considered borderline clinical, 
and scores of 11 and above are considered clinically relevant (Snaith, 2003). The highest score 
possible is 21 for each subscale. The measure has good reliability in somatic, psychiatric and 
primary care patients as well as in the general population (Bjelland, Dahl, Haug, & 
Neckelmann, 2002). In the current study, both the anxiety (α=.84) and depression (α=.77) 
subscales had good reliability.  
 
Data analysis  
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Data were analysed using SPSS 23 (IBM, 2015). The data were not normally distributed and 
therefore non-parametric tests were used when possible. Missing data were excluded using the 
pairwise method apart from in the Mann-Whitney U analysis where the test-by-test method 
was employed. Before the main analysis, descriptive analysis was conducted. For the first aim, 
a Mann-Whitney U test was conducted to determine whether there was a difference in eating 
disorder psychopathology between people who had taken CHT and those who had not. For the 
second aim, preliminary one-tailed Spearman Rho correlations were conducted between the 
dependent variables (drive for thinness and bulimia) and independent variables (age, gender 
assigned at birth, anxiety, depression, self-esteem, body dissatisfaction, interpersonal distrust 
and perfectionism). As categorical variables cannot be entered into correlational analysis, a 
dummy variable was created for gender assigned at birth. The function of the Spearman’s Rho 
correlations was to determine which variables significantly correlated with the dependent 
variables and, consequently, to include only these variables in subsequent regression analysis 
to increase its robustness. Multicollinearity was not a cause for concern as no variable 
correlated at r ≥ .90 with the outcome variables (Pallant, 2010). As multiple comparisons were 
conducted, Bonferroni corrections were used for the correlation analysis (.05 ÷ 16 = .003). To 
determine which variables were able to explain the most variance in eating disorder 
psychopathology (drive for thinness and bulimia) in people who were yet to take CHT, 
stepwise multiple linear regression analysis was conducted. Once the risk factors had been 
established an ANCOVA was conducted to determine whether there was a significant 
difference in eating disorder symptoms between people who were and were not on CHT after 
controlling for the risk factors identified in the multiple linear regression analysis. For the third 
aim, mediation analysis was conducted to better understand the mechanisms that underlie the 
relationship between the independent variable (hypothesised to be body dissatisfaction) and 
eating disorder psychopathology (drive for thinness and bulimia). Mediation analysis was 
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conducted using the PROCESS macro in SPSS (Hayes, 2013). Model 4, which uses the bias-
corrected bootstrap confidence interval method, was employed. The level of significance used 
for all the analysis was p<.05.  




Aim 1: Differences in eating disorder psychopathology between people who were on 
cross-sex hormones and those who were not 
A Mann-Whitney U test was conducted to determine whether participants who were (n=139) 
and were not (n=416) on CHT differed in levels of drive for thinness and bulimia. The analysis 
demonstrated that transgender people who were not on CHT reported significantly higher 
levels of drive for thinness and bulimia compared to participants who were on CHT (see Table 
2).  
 
Mann-Whitney U tests also showed that people who were not on CHT were significantly 
younger, had higher levels of body dissatisfaction and interpersonal distrust, more symptoms 
of anxiety and depression, and lower levels of self-esteem than participants who were on CHT 
(see Table 2). There was no significant difference in levels of perfectionism between the two 
groups. A Pearson Chi-Squared test was conducted to explore differences in gender assigned 
at birth based on CHT use and this test was not significant (χ2 (1) =3.01, p=.083) suggesting 
that gender assigned at birth is independent of CHT.  
 
Insert Table 2 here 
 
Aim 2: Risk factors of eating disorder psychopathology in people who were not on CHT 
Drive for thinness: Body dissatisfaction, high levels of perfectionism, the experience of 
interpersonal distrust, symptoms of anxiety and depression and low self-esteem were all 
significantly correlated with drive for thinness in people who were not on CHT (n=416; see 
Table 3) and were therefore entered into the subsequent stepwise regression analysis. 
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Insert Table 3 here 
 
Overall, the stepwise regression model was significant and the significant variables explained 
30% of the total variance of drive for thinness (see Table 4). Higher levels of body 
dissatisfaction made the largest contribution to the variance followed by high levels of 
perfectionism and anxiety symptoms (see Table 4). The average VIF (variance inflation factor) 
for this model was 1.10 and the average tolerance was 0.91. The average VIF was not greater 
than 10 (Myers, 1990) and the average tolerance was not below 0.10 (Menard, 1995), which 
indicates that the assumptions of multicollinearity for this model were met and hence the 
variables were not too highly correlated.  
 
Bulimia: Body dissatisfaction, high levels of perfectionism, the experience of interpersonal 
distrust, symptoms of anxiety and depression and low self-esteem were all significantly 
correlated with bulimia in people who were not on cross-sex hormones (n=416; see Table 3). 
These six variables were therefore entered into a subsequent stepwise regression model. 
Overall, this model was significant and explained 25% of the total variance in bulimia (see 
Table 4). Low self-esteem made the largest contribution to the variance, followed by high 
levels of perfectionism, body dissatisfaction and symptoms of anxiety (see Table 4). The 
average VIF for this model was 1.38 and the average tolerance was 0.75 indicating that there 
is no multicollinearity within the model (Menard, 1995; Myers, 1990). 
 
Insert Table 4 here 
After determining the risk factors for eating disorder psychopathology in people yet to 
commence cross-sex hormones (n=416), an ANCOVA was conducted to determine whether 
there was a significant difference in eating disorder psychopathology between people who were 
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(n=139) and were not (n=416) on CHT, after controlling for the identified risk factors. It was 
found that there was no longer a significant difference in drive for thinness between people 
who were and were not on CHT when body dissatisfaction, perfectionism and symptoms of 
anxiety were controlled for (F(1, 538) = .35, p=.885). It was also found that there was no longer 
a significant difference in levels of bulimia between people who were and were not on cross-
sex hormones after self-esteem, perfectionism, body dissatisfaction and symptoms of anxiety 
were controlled for (F(1, 529) =.03, p=.868). 
 
Aim 3: Exploring the mediators of the relationship between risk factors and eating 
disorder psychopathology in people who were not on CHT  
In addressing aim 2, it was found that high levels of body dissatisfaction were a risk factor for 
both drive for thinness and bulimia. Due to the centrality of body dissatisfaction in both gender 
incongruence (e.g., Jones et al., 2016, van de Grift et al., 2016, 2017) and eating disorders (e.g., 
Stice & Shaw, 2002), mediators of the relationship between body dissatisfaction and eating 
disorder psychopathology were explored for people who had not yet commenced CHT 
(n=416). The remaining risk factors identified in aim 2 were explored as mediators 
(perfectionism, symptoms of anxiety and self-esteem). Mediation occurs when the 
bootstrapped lower and upper confidence intervals do not include zero.  
 
Perfectionism (model 1) and symptoms of anxiety (model 2) were explored separately as 
mediators of the relationship between body dissatisfaction and drive for thinness. Self-esteem 
(model 3), perfectionism (model 4) and anxiety (model 5) were explored separately as 
mediators of the relationship between body dissatisfaction and bulimia. Figure 1 demonstrates 
the five different models analysed through the direct and indirect effects. As can be seen by the 
unstandardized beta model coefficients (a, b, c) in Table 5, X (the independent variable; body 
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dissatisfaction) always significantly predicted M (the mediator) depicted by pathway (a), and 
M always significantly predicted Y (the outcome variable; drives for thinness or bulimia) 
depicted by pathway (b), in all five models analysed. The direct effect (X-Y; depicted by 
pathway c) was also significant in all models (see Table 5). For the indirect effect, a bias-
corrected bootstrap confidence interval based on 5000 bootstrap sample was explored. As the 
bootstrapped lower and upper confidence intervals did not include zero it can be concluded 
that perfectionism (model 1) and symptoms of anxiety (model 2) each significantly mediated 
the relationship between body dissatisfaction and drive for thinness. This indicates that the 
relationship between body dissatisfaction and drive for thinness can be explained by the 
presence of perfectionism and anxiety symptoms. In addition, self-esteem (model 3), 
perfectionism (model 4) and symptoms of anxiety (model 5) each mediated the relationship 
between body dissatisfaction and bulimia (see Table 5). This indicates that the relationship 
between body dissatisfaction and bulimia can be explained by the low self-esteem, 
perfectionism and anxiety symptoms. 
 
Insert Figure 1 and Table 5 here  




This study aimed to understand the risk factors for eating disorder psychopathology within the 
transgender population, as well as the role of CHT in eating disorder psychopathology. The 
current study found that transgender people who were on CHT had significantly lower levels 
of eating disorder symptoms than transgender people who were not. When comparing this 
finding to previous literature, people within the current study who were on CHT presented with 
similar levels of eating disorder psychopathology compared to the general population 
(Witcomb et al., 2015). In contrast, transgender people in the current study who were not on 
CHT presented with higher levels of eating psychopathology than is found within the general 
population (Witcomb et al., 2015). When the current study’s finding and previous research are 
considered together, it suggests that CHT may be able to alleviate eating disorder 
psychopathology, which is in keeping with previous research (Fisher et al., 2014; Khoosal et 
al., 2009) and case studies (Couturier et al., 2015; Winston et al., 2004) that have supported 
the notion that eating disorder psychopathology in transgender people is secondary to gender 
incongruence.  
 
This study is novel in that it aimed to understand why CHT might alleviate eating disorder 
symptoms by exploring risk factors in transgender people yet to undergo a medical transition. 
The current study found that high levels of body dissatisfaction, perfectionism, symptoms of 
anxiety, and low self-esteem were all risk factors for eating disorder psychopathology as 
reported in the cisgender literature (e.g., Brechan & Kvalem, 2013; Dakanalis et al., 2016; Egan 
et al., 2011; Fairburn et al., 2003; Keel et al., 1997; Puccio et al., 2017; Tchanturia et al., 2016). 
Once the identified risk factors for eating disorder psychopathology were controlled for, there 
was no longer a significant difference in eating disorder symptoms between people who were 
and were not on CHT. This finding suggests that CHT alleviates eating disorder symptoms as 
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it reduces levels of body dissatisfaction, perfectionism, symptoms of anxiety and increases self-
esteem.  
 
Within the cisgender literature, body dissatisfaction has been described as a core feature of – 
though not sufficient to adequately explain - eating disorder symptoms (Polivy & Herman, 
2002) and, consequently, other factors have been found to mediate the relationship between 
body dissatisfaction and eating disorder psychopathology (e.g., Brechan & Kvalem, 2015; 
DeBoer & Smits, 2013; Fairburn et al., 2003; Harrison et al., 2009). This also appears to be the 
case within the transgender population as the current study found high levels of perfectionism 
and symptoms of anxiety to mediate the relationship between body dissatisfaction and drive 
for thinness. Additionally, low self-esteem, high levels of perfectionism and symptoms of 
anxiety were found to mediate the relationship between body dissatisfaction and bulimia in 
transgender individuals. These findings help to clarify the mechanisms through which CHT 
might be able to alleviate eating disorder symptoms. They suggest that CHT primarily 
alleviates high body dissatisfaction, which in turn reduces levels of perfectionism and 
symptoms of anxiety, and increases self-esteem. In combination, these factors then appear to 
alleviate eating disorder symptoms. This is the first study with transgender people that has been 
able to indicate how cross-sex hormones alleviate eating disorder symptoms, although this 
finding needs to be replicated with longitudinal research.  
 
Clinicians working in eating disorder services should routinely assess gender identity issues as 
this is where transgender people may first present due to experiencing high levels of body 
dissatisfaction and eating disorder symptoms that are secondary to gender incongruence. Such 
patients should be referred to transgender health services as this study has shown the positive 
role that CHT plays in eating disorder symptoms. CHT is likely to be more effective than 
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interventions offered at eating disorder services in these circumstances (Ewan, Middleman, & 
Feldmann, 2014). However, there are likely to be a small number of patients that also require 
eating-related interventions. To determine whether this is suitable, the role of eating disorder 
psychopathology will need to be assessed. In our clinical experience, the presence of eating 
disorder psychopathology, such as food restriction, is engaged in to stop the development of 
secondary sex characteristics that are related to the individual’s assigned gender, such as breast 
development or menstruation. However, in some cases, CHT alone may not be enough to 
reduce eating disorder psychopathology and clinicians at transgender health and eating disorder 
services may need to work together to alleviate eating disorder psychopathology whilst also 
facilitating access to gender affirming medical interventions.  
 
When patients are referred to transgender health services with symptoms of eating disorders, 
clinicians might be reluctant to accept such patients onto the treatment programme until these 
issues are resolved. The findings of the current study indicate that for patients presenting with 
high levels of eating disorder symptoms (that are secondary to gender identity issues), timely 
initiation of CHT may likely reduce these symptoms, as well as their gender incongruence. 
Given the existence of significant barriers to accessing transgender health care (Bouman & 
Richards, 2013; Jones et al., 2017; Kanamori & Cornelius-White, 2016; Scheim, Zong, Giblon, 
& Bauer, 2017), it is imperative that access to these services is increased to minimise the risk 
of eating disorder psychopathology. In addition, although gender affirming medical 
interventions alleviate body dissatisfaction (a core feature of eating disorder psychopathology) 
for many, patients who report very high body dissatisfaction pre-gender affirming medical 
interventions have been found to continue to do so post-gender affirming medical interventions 
(van de Grift et al., 2017). Clinicians at transgender health services must consider that these 
patients (who report high body dissatisfaction post-gender affirming interventions) may be 
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vulnerable to eating disorder psychopathology and therefore may require eating-related 
interventions.  
 
Within the current study, neither age or gender (assigned at birth) were found to be risk factors 
for eating disorder psychopathology within treatment seeking transgender people who were yet 
to commence CHT. This contrasts with research within the cisgender population which has 
found adolescents and young adult females to be at greater risk than males and older people 
(e.g., Fairburn & Harrison, 2003; Zeiler et al., 2016) and was despite the current study finding 
that people who were yet to commence CHT were significantly younger (and reported more 
eating disorder symptoms) than people who had initiated CHT. Previous research with 
transgender people has found transgender men (assigned female at birth) to report very high 
levels of body dissatisfaction (a common feature of eating disorder psychopathology) that were 
comparable to cisgender men with an eating disorder (Witcomb et al., 2015). This finding was 
not replicated when transgender women were compared to cisgender women with an eating 
disorder (Witcomb et al., 2015). Therefore, although gender may not be a risk factor for eating 
disorder symptoms within the transgender population, clinicians in both eating disorder and 
transgender health services should be mindful that levels of body dissatisfaction among people 
assigned female at birth may mean that the prevalence of eating disorder symptoms is higher 
than in people assigned male at birth.  
 
For the first time, the current study has identified multiple risk factors for eating disorder 
psychopathology within a large sample of treatment seeking transgender people. In addition to 
this, the alleviating role that CHT plays in eating disorder symptoms has been recognised. This 
is in contrast to previous research, which has found levels of eating disorder symptoms in the 
transgender population to be higher than in the general population without understanding why 
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(Witcomb et al., 2015). However, the following limitations should be considered. First, this 
study is cross-sectional and therefore causality cannot be determined. Risk factors need to be 
explored with further longitudinal research. Second, the group sizes within the comparative 
analysis were different which might have impacted on the findings. Finally, analysis was 
conducted in relation to gender assigned at birth. The majority of transgender people will 
transition within the binary gender system (i.e., man or woman) but there are increasing 
numbers of transgender people who identify outside the binary gender system (i.e., gender 
neutral, non-gender, bigender, third gender) or are fluid with their gender identity (Arcelus & 
Bouman, 2017a). Therefore, future research should be concerned with transgender people who 
identify as a woman, a man, and outside the binary gender system.  
 
In conclusion, transgender people who were not on CHT reported more eating disorder 
symptoms than transgender people who were on CHT. The findings suggest that CHT may be 
able to alleviate eating disorder symptoms primarily through positively impacting on body 
dissatisfaction (i.e., increasing body satisfaction) which, in turn, reduces levels of 
perfectionism and symptoms of anxiety and increases self-esteem. Clinicians working at eating 
disorder services should incorporate the assessment of gender identity issues within their 
clinical practice and refer patients with such issues to transgender health services so that they 
can be evaluated for CHT.  
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Table 1: Socio-demographic characteristics for the whole sample, for participants who have 
taken cross-sex hormones, and for participants who have not taken cross-sex hormones  







 Sample size (%) 
Mean (SD) age 29.49 (13.67) 35.37 (16.02) 27.46 (12.15) 
Gender assigned at birth    
Female 211 (37.5) 44 (31.7) 166 (39.9) 
Male 352 (62.5) 95 (68.3) 250 (60.1) 
Cross-sex hormones    
Yes (excluding blockers only) 139 (24.7)   
No 416 (73.9)   
No response 8 (1.4)   
Blockers only (no CHT)   17 (4.1) 
Note: CHT (cross-sex hormone treatment); †People who had only taken blockers (and not 
CHT) were excluded from the cross-sex hormones group as in contrast to CHT; hormone 
blockers do not affect secondary sex characteristics. Based on this, these people were included 
within the no cross-sex hormone group.  
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Table 2: Means, standard deviations (SD) and Mann Whitney U tests of difference between 
people who have taken CHT and those who have not for all study variables 
 No CHT 
(n=416) 
CHT (n=139) Mann-Whitney U 
M (SD) M (SD) U Z p 
Age 27.46 (12.15) 35.37 (16.02) 20126.50 -5.38 .001 
Drive for thinness  3.87 (4.95) 2.82 (4.07) 25207.50 -2.14 .019 
Bulimia 1.87 (3.54) 0.96 (2.32) 24178.00 -2.99 .002 
Body dissatisfaction  12.13 (6.96) 9.62 (6.83) 22368.00 -3.86 .001 
Interpersonal distrust 5.66 (4.60) 3.56 (3.86) 20609.50 -4.72 .001 
Anxiety 8.27 (4.31) 6.45 (4.00) 21021.50 -4.39 .001 
Depression 7.22 (3.88) 5.18 (3.48) 19270.50 -5.37 .001 
Self-esteem  14.74 (6.52) 19.01 (6.49) 17849.00 -6.31 .001 
Perfectionism  5.10 (4.19) 4.88 (3.86) 27975.50 -.28 .410 
CHT (cross-sex hormone treatment)
Eating disorder psychopathology in transgender people  
35 
 
Table 3: One-tailed Spearman’s Rho correlations between drive for thinness, bulimia and the 
study variables for people who have not taken CHT (n=416) 
 Drive for 
thinness 
Bulimia 
Age .01 -.12 
Male gender assigned at birth† -.05 -.07 
Female gender assigned at birth† .05 .07 
Body dissatisfaction   .48*** .31*** 
Perfectionism .24*** .26*** 
Interpersonal distrust .27*** .30*** 
Anxiety .35*** .36*** 
Depression .30*** .28*** 
Self-esteem -.37*** -.48*** 
*p<0.05, **p<0.01, ***p<0.001 (corrected for multiple comparisons); † entered as dummy 
variables  
CHT (cross-sex hormone treatment) 
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Table 4: Stepwise regression models showing the significant risk factors of (i) drive for 
thinness and (ii) bulimia for people who have not taken CHT (n=416) 
 F R2 beta SE beta β 
Drive for thinness 57.32*** .30    
Body dissatisfaction .31 .03 .43*** 
Perfectionism .18 .05 .16*** 
Anxiety .18 .05 .16*** 
Bulimia 32.86*** .25    
Self-esteem -.13 .03 -.24*** 
Perfectionism .15 .04 .18*** 
Body dissatisfaction  .08 .02 .16*** 
Anxiety   .12 .05 .14** 
*p<0.05, **p<0.01, ***p<0.001 
CHT (cross-sex hormone treatment) 
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Table 5: Perfectionism, self-esteem and anxiety as potential mediators of the relationship between body dissatisfaction and eating disorder 
psychopathology (drive for thinness and bulimia) in people who have not taken CHT (n=416) 
 Regression model unstandardized beta coefficients for paths a, b, c and ab and bootstrapped lower and upper 
confidence intervals 







lower CI  
Bootstrap 
upper CI  
Drive for thinness        
 Model 1: Perfectionism  .09** .23*** .33*** .02 .01 .04 
 Model 2: Anxiety .15*** .23*** .31*** .03 .02 .06 
Bulimia        
 Model 3: Self-esteem -.39*** -.19*** .10** .07 .05 .10 
 Model 4: Perfectionism .09*** .29*** .14*** .02 .01 .04 
 Model 5: Anxiety .15*** .25*** .12*** .04 .02 .06 
*p<0.05, **p<0.01, ***p<0.001, X-body dissatisfaction, M-mediator variable (perfectionism, self-esteem and anxiety), Y-outcome variable (drive 
for thinness or bulimia).  CHT (cross-sex hormone treatment) 




Predictor variable (X): 
Body dissatisfaction
Outcome variables (Y):














Figure 1: Mediation analyses for perfectionism and anxiety as mediators between body 
dissatisfaction and drive for thinness and, for self-esteem, perfectionism and anxiety as 
mediators between body dissatisfaction and bulimia  
 
